He's not likely to make any real news in Boston tomorrow, but we'll likely listen in just the same. [I suppose he might comment on BMS getting priority review for Opdivo®, in NSCLC -- and Merck's catch-up plans.] We may liveblog any real news:
. . . .Adam Schechter, executive vice president and president, Global Human Health, Merck, is scheduled to present at the 35th Annual Cowen Health Care Conference in Boston on Mar. 3, 2015 at 8:40 a.m. EST.
Investors, analysts, members of the media and the general public are invited to listen to a live audio webcast of the presentation. . . .
So, do stop back by -- around 8:40 Eastern tomorrow morning. I doubt he'll discuss anything new and material -- but who knows?